Regn investor notice: robbins geller rudman & dowd llp announces that regeneron pharmaceuticals, inc. investors with substantial losses have opportunity to lead class action lawsuit

San diego--(business wire)--the suit alleges defendants issued false statements concerning regeneron business and prospects, resulting in its stock trading at inflated prices.

REGN Ratings Summary

REGN Quant Ranking